Psychosocial and Ethical Implications of Defining Genetic Risk for Cancersa
- 1 September 1995
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 768 (1) , 41-52
- https://doi.org/10.1111/j.1749-6632.1995.tb12107.x
Abstract
In summary, we need to provide fully informed consent regarding the hazards and the benefits of genetic testing and defining risk. This reflects the first ethical principle of autonomy. It is the responsibility of the counseling team to make sure that the individual is psychologically equipped to deal with the emotional distress that may result from testing. An undue burden must not be placed on someone and harm must not be inflicted. This is the second ethical principle of beneficence. Third, awareness of the potential problems of testing is extremely important. These issues are those of disclosure, insurance problems, and employment problems--the third ethical principle of confidentiality. Recommendations for screening guidelines, regardless of testing results, should be provided. It is important for women who are not gene carriers to know that they still need to go for screening. Lastly, we need to find ways to help individuals cope with their risk status, whether it is actual high risk or perceived high risk. Helping women to develop positive coping strategies and to adhere to screening is extremely important. As the Huntington's data indicated, over time, regardless of their risk levels, individuals do learn how to cope and adapt with the outcome of testing. Women and men need to learn how to live with their risk status so that the negative psychological sequelae will be minimized.Keywords
This publication has 25 references indexed in Scilit:
- Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington DiseasePublished by American Medical Association (AMA) ,1993
- DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family studyArchives of internal medicine (1960), 1993
- Presymptomatic DNA‐testing for Huntington disease: Pretest attitudes and expectations of applicants and their partners in the Dutch programAmerican Journal of Medical Genetics, 1993
- Inherited breast and ovarian cancer. What are the risks? What are the choices?Published by American Medical Association (AMA) ,1993
- Genetic counseling for families with inherited susceptibility to breast and ovarian cancerJAMA, 1993
- Interest in Genetic Testing for Colon Cancer Susceptibility: Cognitive and Emotional CorrelatesPreventive Medicine, 1993
- Psychological Distress and Surveillance Behaviors of Women With a Family History of Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Familial breast-ovarian cancer locus on chromosome 17q12-q23The Lancet, 1991
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990
- Prevention in familial breast cancer: counseling and prophylactic mastectomyPreventive Medicine, 1982